Worcester Polytechnic Institute

AIChE Selected by DOE to Lead New Hydrogen Electrolyzer and Fuel Cell Recycling Consortium 

Retrieved on: 
Tuesday, March 26, 2024
Hydrogen, Delaware State University, University of Houston, Worcester Polytechnic Institute, Plug Power, Oak Ridge National Laboratory, National Renewable Energy Laboratory, Recycling, Chemours, Research, University, American Institute, RDD, University of Delaware, RD, DOE, General Motors, Electrolysis, Renewable energy

Among the recipients, the American Institute of Chemical Engineers (AIChE) was selected to lead H2CIRC, a new “recovery and recycling” consortium charged with developing innovative and practical approaches to enable the recovery, recycling, and reuse of materials and components for hydrogen fuel cells and electrolyzers.

Key Points: 
  • Among the recipients, the American Institute of Chemical Engineers (AIChE) was selected to lead H2CIRC, a new “recovery and recycling” consortium charged with developing innovative and practical approaches to enable the recovery, recycling, and reuse of materials and components for hydrogen fuel cells and electrolyzers.
  • This development will be supported by federal funding to be awarded to AIChE for the Hydrogen Electrolyzer and Fuel Cell Recycling Consortium, which totals $50 million over five years.
  • Additional DOE funding is being awarded for projects including low-cost, high-throughput electrolyzer manufacturing; electrolyzer component and supply chain development; advanced technology and component development; advanced manufacturing of fuel cell assemblies and stacks; and fuel cell supply chain development.
  • AIChE and its consortium partners will establish a blueprint across the industry for recycling electrolyzer and fuel cell systems and components, aimed at securing long-term supply chain security and environmental sustainability.

Worcester Polytechnic Institute Launches First-in-the-Nation Financial Technology PhD; Only University in the U.S. to Offer All Degree Levels in FinTech

Retrieved on: 
Tuesday, April 9, 2024
Hardware, Data Management, Technology, University, Finance, Fintech, Education, Professional Services, Other Technology, Science, Software, Networks, Other Science, Mobile, Wireless, Research, Worcester Polytechnic Institute, Growth, Data science, Blockchain, Knowledge, Business school, Ethics, Management, AI, Faculty, Doctor of Philosophy, Dean, Student, Statistics, Mathematics, Ecosystem, WPI

Building on its established master’s and bachelor’s degree programs and aiming to meet industry trends and demands, Worcester Polytechnic Institute (WPI) has introduced the nation’s first PhD program in Financial Technology (FinTech).

Key Points: 
  • Building on its established master’s and bachelor’s degree programs and aiming to meet industry trends and demands, Worcester Polytechnic Institute (WPI) has introduced the nation’s first PhD program in Financial Technology (FinTech).
  • The new program underscores WPI’s dedication to advanced education and research in this rapidly expanding sector, making it the only university in the country to offer all degree levels in the field.
  • FinTech has become an essential area of study, creating a need for PhD graduates with the skills to lead industry and teach in financial technology programs.
  • There are also industry research opportunities, as firms in the financial industry seek to create innovative operations and products based on emerging financial technologies.

Rentschler Biopharma Takes Home the Gold in 20th Annual Team Massachusetts Economic Impact Awards

Retrieved on: 
Wednesday, March 13, 2024
Worcester Polytechnic Institute, CDMO, Organization, Gillette Stadium, CGMP, Central Massachusetts, New England Patriots, New England Revolution, Workforce, WPI, Gold Award

LAUPHEIM, Germany and MILFORD, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced that the company’s U.S. subsidiary, Rentschler Biopharma Inc., has been honored with the Gold Award for the Central Massachusetts region in the 20th Annual Team Massachusetts Economic Impact Awards.

Key Points: 
  • LAUPHEIM, Germany and MILFORD, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced that the company’s U.S. subsidiary, Rentschler Biopharma Inc., has been honored with the Gold Award for the Central Massachusetts region in the 20th Annual Team Massachusetts Economic Impact Awards.
  • The awards will be presented on April 11 at a ceremony at Gillette Stadium, home of the New England Patriots football team and the New England Revolution soccer team.
  • MassEcon, the private sector partner in promoting business growth in the state of Massachusetts, recognizes Rentschler Biopharma along with thirteen other companies for its outstanding contributions to the state’s economy.
  • Tom Roberts, President of Rentschler Biopharma Inc. and General Manager U.S., said: “We are proud to be part of the Massachusetts biopharma community and to contribute to the state’s economic growth.

Consumer Safety Technology Names Three New Executives Strengthening Leadership and Supporting Accelerated Growth Plans

Retrieved on: 
Tuesday, March 19, 2024
Financial management, Worcester Polytechnic Institute, Adtalem Global Education, Growth, University, Communication, CFO, Business, Education, History, Dartmouth College, Kellogg School of Management, Record, Engineering, MBA, Eschelon Telecom, Distinction, B.A, CST, Kelley School of Business, Sirius XM, Management

DES MOINES, Iowa, March 19, 2024 /PRNewswire/ -- Consumer Safety Technology, a leader in substance-use safety and detection products and services, announced today the appointment of three executives to its top leadership team.

Key Points: 
  • DES MOINES, Iowa, March 19, 2024 /PRNewswire/ -- Consumer Safety Technology, a leader in substance-use safety and detection products and services, announced today the appointment of three executives to its top leadership team.
  • His proven track record of driving financial performance in subscription-based businesses, leading through change, and building out scalable and repeatable processes will be instrumental in achieving growth objectives.
  • Robbins offers a unique blend of leadership, compliance and operational expertise, with a strong background in cross-enterprise management in highly regulated industries.
  • His background and strong leadership capabilities will enable CST to accelerate product and industry leading innovation.

Opentrons Announces Medical Robotics Expert Gregory Cole as Chief Innovation Officer to Accelerate AI-Driven Robo-Lab Partnerships and Innovations

Retrieved on: 
Thursday, February 22, 2024
Robotics, Technology, Other Science, Research, Artificial Intelligence, Science, Hardware, Doctor of Philosophy, Multimedia, Cole, History, Worcester Polytechnic Institute, IP, 3D printing

Opentrons Labworks, Inc. , a leader in lab automation and makers of accessible lab robotics, today announced the appointment of Gregory Cole, PhD as Chief Innovation Officer.

Key Points: 
  • Opentrons Labworks, Inc. , a leader in lab automation and makers of accessible lab robotics, today announced the appointment of Gregory Cole, PhD as Chief Innovation Officer.
  • View the full release here: https://www.businesswire.com/news/home/20240222831212/en/
    "Greg's remarkable experience underscores his proficiency in steering robotic technologies towards successful commercialization," said Jonathan Brennan-Badal, CEO of Opentrons.
  • Dr. Cole served as Chief Technology Officer and Advisor at AiM Medical Robotics, responsible for developing and manufacturing image-guided robotic surgical devices and R&D platforms.
  • I’m looking forward to bringing my expertise in engineering to help them advance Opentrons Flex and other automated solutions," said Dr. Cole.

YS Biopharma Announces Appointment of New Directors

Retrieved on: 
Wednesday, February 14, 2024
CFO, Peking University, Doctor of Philosophy, Project, Legal Affairs, Wanda Group, MBA, Vaccine, General counsel, Shanxi University, Interim, Chairperson, Comptroller, University, Partner, Business administration, Renmin University of China, Biomedical sciences, Business, JD, Ernst & Young, Worcester Polytechnic Institute, International law, Infection, Chemical engineering, YS, DXY, Washington State University, Cancer, Management

GAITHERSBURG, Md., Feb. 14, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company", and together with its subsidiaries, "YS Group"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced the appointment of six new members to its Board of Directors (the "Board"), effective February 13, 2024.

Key Points: 
  • GAITHERSBURG, Md., Feb. 14, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company", and together with its subsidiaries, "YS Group"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced the appointment of six new members to its Board of Directors (the "Board"), effective February 13, 2024.
  • Ms. Chunyuan (Brenda) Wu currently serves as the CFO of YS Group, a position she has held since December 31, 2020.
  • Previously, Ms. Wu served as CFO of YS Group Biopharma from 2018-2020, and as Financial Controller for the same company from 2013-2018.
  • Dr. Ajit Shetty, Chairperson of the Board of Directors of the Company, commented, "We are pleased to welcome each of our new directors to the Board.

Imperative Care Announces Four Senior Leadership Appointments

Retrieved on: 
Monday, January 29, 2024
Medical Devices, Health, Health Technology, General Health, Cardiology, Biotechnology, Diabetes, Senior, Worcester Polytechnic Institute, Patient, CLO, LLP, CSO, Industrial engineering, Knowledge, Business administration, Stroke, University, Khosravi, Business, Law, PepsiCo, Executive, Babson College, Delaware Valley University, Daniel, Exceptional Minds, Industrial, Harman International, Organization, Master, Drink, Growth, Management

“This is an inflection point of operational scale and excellence for Imperative Care, and we are thrilled to have Chuck lead this important mission,” said Fred Khosravi, Imperative Care’s CEO and Chairman.

Key Points: 
  • “This is an inflection point of operational scale and excellence for Imperative Care, and we are thrilled to have Chuck lead this important mission,” said Fred Khosravi, Imperative Care’s CEO and Chairman.
  • Daniel will continue his important contributions to the future of patient care with his resolute dedication to meaningful innovation.”
    As an accomplished executive leader, Chuck Alpuche brings more than 40 years of senior operational expertise.
  • Prior to joining Imperative Care, he served as the Executive Vice President and COO of Insulet Corporation (NASDAQ: PODD).
  • Peter Griffin joins Imperative Care as a seasoned operations leader with more than 35 years of manufacturing, strategic supplier management, and product development experience.

ReAlta Life Sciences Strengthens Board of Directors with Appointment of Three Accomplished Biotechnology Executives

Retrieved on: 
Wednesday, January 3, 2024
Science, Other Science, Biotechnology, Research, Pharmaceutical, General Health, Health, Clinical Trials, Kite Pharma, Engineering management, Tufts University, Marketing, Lilly, Migraine, Johnson & Johnson, Amgen, Sale, AstraZeneca, Daiichi Sankyo, Eli Lilly, Jan Vansina, Business administration, Engineering, WebMD, MBA, Chemical engineering, Doctor of Philosophy, Roivant Sciences, Therapy, Eli Lilly and Company, Consumer service, University, Washington State University, Worcester Polytechnic Institute, Iowa State University, SVP, Corporation, Pharmaceutical industry

ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a mid-stage clinical biotech company dedicated to saving lives by rebalancing the inflammatory response to address life-threatening diseases, today announced the appointment of three seasoned biotechnology executives, Christi Shaw, Mert Aktar, and David Marek, to its Board of Directors, effective immediately.

Key Points: 
  • ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a mid-stage clinical biotech company dedicated to saving lives by rebalancing the inflammatory response to address life-threatening diseases, today announced the appointment of three seasoned biotechnology executives, Christi Shaw, Mert Aktar, and David Marek, to its Board of Directors, effective immediately.
  • “We are delighted to welcome Christi Shaw, Mert Aktar and David Marek, and the tremendous expertise and wise counsel they represent, to our Board of Directors,” said Buzz Heidt, Chairman of ReAlta's Board of Directors.
  • Prior to Kite, Ms. Shaw served as an executive officer of Eli Lilly and Company (Lilly), a global healthcare company, and president of Lilly Bio-Medicines.
  • Mr. Aktar is an accomplished life sciences industry executive with over twenty years of multinational experience bridging science and business in pharmaceuticals and biotechnology.

Headwall Announces Mark Willingham as Chief Executive Officer

Retrieved on: 
Thursday, December 14, 2023
OEM, Fortive, MBA, United States Navy, Worcester Polytechnic Institute, Engineering, Growth, Management

Bolton, Massachusetts, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Headwall Photonics®, a leading manufacturer of high-performance hyperspectral imaging systems and OEM optical spectroscopy devices for applications in remote sensing and industrial machine vision—including food quality/safety inspection, precision agriculture, and environmental monitoring—today announced Mark Willingham as Chief Executive Officer.

Key Points: 
  • Bolton, Massachusetts, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Headwall Photonics®, a leading manufacturer of high-performance hyperspectral imaging systems and OEM optical spectroscopy devices for applications in remote sensing and industrial machine vision—including food quality/safety inspection, precision agriculture, and environmental monitoring—today announced Mark Willingham as Chief Executive Officer.
  • "We are thrilled to welcome Mark Willingham to the Headwall team," said Marc Tremblay, operating partner at Arsenal Capital Partners.
  • Mark Willingham is a seasoned executive with a diverse background in both engineering and business.
  • "I am honored to join Headwall, a company known for its cutting-edge technology and commitment to excellence," said Mark Willingham.

WPI Establishes Master’s Degree in Artificial Intelligence to Prepare Students for Growing Field

Retrieved on: 
Thursday, December 14, 2023
Education, Technology, Artificial Intelligence, University, Medicine, School, Business school, Bureau of Labor Statistics, The arts, Research, Behavior, Specialization, Mathematics, Data science, Global Investors Summit, Synthetic media, BLS, Student, Multimedia, Faculty, Computer science, Artificial intelligence, Science, Intelligence, Occupation, Health, Statistics, Computer, Automation, Curriculum, PwC, WPI, Deep learning, Human, Worcester Polytechnic Institute, Environment, Information technology, Robotics, Workplace, Government, Nursing, Management, Engineering, AI

View the full release here: https://www.businesswire.com/news/home/20231214319641/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231214319641/en/
    WPI will begin accepting applications for the new AI program immediately for enrollment in fall 2024.
  • (Photo: Business Wire)
    WPI will offer students flexible, yet highly rigorous, areas of specialization with courses on subjects ranging from deep learning to generative AI.
  • The program will combine theory and practice to train students in the understanding, development, deployment, and innovation of AI techniques and systems.
  • Graduate Certificate: This option will prepare students to use AI technologies in real-world applications by completing four thematically related graduate courses in AI.